WHO on Thursday has warned for probable spread of Zika virus across the North and Central American countries. Ahead of rising concerns for Zika spreading, drug makers and scientists have commented that manufacturing of an appropriate vaccine may even require a decade. These warnings has opened a huge business potential for Oxitec, an Intrexon subsidiary. Oxitec’s gene modified mosquitoes are capable of ensuring security against Zika for large populations.
Intrexon Corp.
Breaking News
A PricewaterhouseCoopers report revealed that venture capitalist invested around US$320 million into Maryland last quarter.
A biotech company wants to raise US$125 million through its IPO.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Social Security Benefits to Increase for Some Seniors After Addressing Overpayment Issues
- Businessman Brutally Murdered Allegedly by 4 of His Workers Who Swung an Axe Into His Head
- North Korea Refuses Peace Talk With Japan Unless They Confront Their 'Brutal' History; Business Relations at Risk
- Hunter Biden Asks Court to Junk $1.4 Million Tax Evasion Case as Politically Motivated, But Judge Appears Skeptical